Literature DB >> 23851116

Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.

Li Yuan1, ChangWei Song, CaiHu Li, Ying Li, Lin Dong, ShuFan Yin.   

Abstract

A series of pyrazolo[3,4-d]pyrimidine analogues 3, 4, 5a-f, 6a-f with various amines and ester groups at C-4 and N-1 were synthesized and evaluated for antitumour activity. They were also evaluated for xanthine oxidase inhibitory activity, with most compounds having no significant impact. Compound 5e had the strongest activity against human hepatoma carcinoma cells 7402 and 7221, with half-maximal inhibitory concentration values of 4.55 and 6.28, respectively. Structure-activity relationship studies indicate that chlorine atoms in the structure of 4-((4-(substituted amides)phenyl)amino pyrazolo[4,3-d]pyrimidine analogues is crucial for antitumour activity.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  17AAG; Allopurinol; Antitumour; Pyrazolo[3,4-d]pyrimidines; XOD

Mesh:

Substances:

Year:  2013        PMID: 23851116     DOI: 10.1016/j.ejmech.2013.05.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  The crystal structure of 1,5-dibenzyl-1H-pyrazolo-[3,4-d]pyrimidine-4(5H)-thione.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-10

2.  Crystal structure of 4-allyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-23

3.  Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition.

Authors:  Yong Li; Ting-Ting Cao; Shanchun Guo; Qiu Zhong; Cai-Hu Li; Ying Li; Lin Dong; Shilong Zheng; Guangdi Wang; Shu-Fan Yin
Journal:  Molecules       Date:  2016-06-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.